135 related articles for article (PubMed ID: 33189426)
1. Cluster randomized controlled trial of volitional and motivational interventions to improve bowel cancer screening uptake: A population-level study.
Wilding S; Tsipa A; Branley-Bell D; Greenwood DC; Vargas-Palacios A; Yaziji N; Addison C; Kelly P; Day F; Horsfall K; Conner M; O'Connor DB
Soc Sci Med; 2020 Nov; 265():113496. PubMed ID: 33189426
[TBL] [Abstract][Full Text] [Related]
2. A randomised controlled trial of volitional and motivational interventions to improve cervical cancer screening uptake.
Wilding S; Wighton S; West R; Conner M; O'Connor DB
Soc Sci Med; 2023 Apr; 322():115800. PubMed ID: 36858020
[TBL] [Abstract][Full Text] [Related]
3. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
[TBL] [Abstract][Full Text] [Related]
5. Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme.
White B; Power E; Ciurej M; Lo SH; Nash K; Ormiston-Smith N
Biomed Res Int; 2015; 2015():928251. PubMed ID: 26525423
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
Murphy J; Halloran S; Gray A
BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
[TBL] [Abstract][Full Text] [Related]
7. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a brief phone intervention to increase participation in a population-based colorectal cancer screening programme: a randomized controlled trial.
Selva A; Torà N; Pascual E; Espinàs JA; Baré M
Colorectal Dis; 2019 Oct; 21(10):1120-1129. PubMed ID: 31099455
[TBL] [Abstract][Full Text] [Related]
10. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
[TBL] [Abstract][Full Text] [Related]
11. Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study.
Castanon A; Parmar D; Massat NJ; Sasieni P; Duffy SW
J Natl Cancer Inst; 2022 Sep; 114(9):1262-1269. PubMed ID: 35575409
[TBL] [Abstract][Full Text] [Related]
12. Including a general practice endorsement letter with the testing kit in the Bowel Cancer Screening Programme: Results of a cluster randomised trial.
Cross AJ; Myles J; Greliak P; Hackshaw A; Halloran S; Benton SC; Addison C; Chapman C; Djedovic N; Smith S; Wagner CV; Duffy SW; Raine R
J Med Screen; 2021 Dec; 28(4):419-425. PubMed ID: 33645308
[TBL] [Abstract][Full Text] [Related]
13. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening.
Bretagne JF; Piette C; Cosson M; Durand G; Lièvre A
Dig Liver Dis; 2019 Oct; 51(10):1461-1469. PubMed ID: 31151896
[TBL] [Abstract][Full Text] [Related]
14. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
15. Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: a cluster-randomised trial.
Smith SG; Wardle J; Atkin W; Raine R; McGregor LM; Vart G; Morris S; Duffy SW; Moss S; Hackshaw A; Halloran S; Kralj-Hans I; Howe R; Snowball J; Handley G; Logan RF; Rainbow S; Smith S; Thomas M; Counsell N; von Wagner C
BMC Cancer; 2017 Aug; 17(1):543. PubMed ID: 28806955
[TBL] [Abstract][Full Text] [Related]
16. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
17. Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths.
Geurts SM; Massat NJ; Duffy SW
Br J Cancer; 2015 Jun; 113(1):142-9. PubMed ID: 26110973
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
[TBL] [Abstract][Full Text] [Related]
20. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis.
Jager M; Demb J; Asghar A; Selby K; Mello EM; Heskett KM; Lieberman AJ; Geng Z; Bharti B; Singh S; Gupta S
Dig Dis Sci; 2019 Sep; 64(9):2489-2496. PubMed ID: 30915656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
